Pharmaceutical Technology\'s In the Lab eNewsletter-11-06-2019

Using automation and taking a step-by-step approach can facilitate the process of selecting a top-quality cell-line source.

Industry experts examine the fundamentals of dissolution testing, including challenges resulting from an increasing number of poorly soluble molecules under development in the pharmaceutical pipeline.

In response to customer requests for a more secure closure, the company equipped the new lab coat with a nylon zipper and no-pocket design, rather than the typical snap design, which runs the risk of contamination to people and processes.

The new device is a modular system made to integrate into isolators or RABS, using an external controller and remotely located air mover.

The new device guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.

Waters will join several venture investors including, Floodgate Capital, First Round Capital, Underscore VC, Founder Collective, and Y Combinator, to invest in TetraScience’s $8-million series A round of financing.

The company is expanding its bioanalytical capacity and capabilities to support biologic drug development, cell and gene therapy development, and biomarker analysis.

Clear Advantage is a product line of multichannel reagent reservoirs to be used for creating a next-gen sequencing library

The new services provide rapid production of antibody drug conjugates (ADCs) for best candidate selection.

The companies agreed to a multi-year research and development collaboration that will focus on AI empowerment and exploration.

The new incubators are set to be operational starting in 2021.